| PUBLICATIONS FOR HEALTH PROFESSIONALS
Publications - Key database I CKD in Australia I eGFR Tools inc eGFR Calculator I Home Dialysis Survey
AUSTRALIAN INSTITUTE OF HEALTH AND WELFARE
Reports on Chronic Kidney Disease (CKD)
 Chronic kidney disease in Aboriginal and Torres Strait Islander people 2011
ISBN 978-1-74249-203-2; Cat. no PHE 151; 74pp.y
Internet only - September 2011 Cat no PHE 151 Canberra AIHW 2011
People with CKD, particularly those with end-stage kidney disease (ESKD), suffer poor health outcomes and a decreased quality of life. Indigenous Australians were found to be more likely to have end-stage kidney disease and be hospitalised or die with CKD than non-Indigenous Australians. Aboriginal and Torres Strait Islander people, especially those who live in remote communities, are at a greater risk of developing CKD and have substantially poorer health outcomes than other Australians. To date information on CKD in Aboriginal and Torres Strait Islander people at the national level has been limited to high-level summary information.
Aboriginal and Torres Strait Islander Health Performance Framework 2010: detailed analyses
AIHW 2011 Cat no IHW 53 Canberra - Refer 1.09 End stage renal disease (451KB PDF) pp 230-252. ISSN 978-1-74249-152-3; Cat no IHW 53; 2150pp.; 27 September 2011 Internet Only
Detailed analyses underlying summary data presented in the Aboriginal and Torres Strait Islander Health Performance Framework 2010, which consists of 71 measures covering the tiers: health status and outcomes; determinants of health; and health systems performance.
Projections of the incidence of treated End-Stage Kidney Disease in Australia, 2010-2020
AIHW catalogue number (PHE150) Internet only - 15 September 2011Projections are made by sex at national and state/territory levels, and for end-stage kidney disease (ESKD) patients with diabetes when commencing treatment. The incidence of treated ESKD is projected to continue to rise, increasing by nearly 80% between 2009 and 2020. The proportion of those commencing ESKD treatment with diabetes is also expected to increase, from 45% in 2009 to 64% in 2020.
Central Australia Renal Study
The George Institute for Global Health on behalf of the Commonwealth Department of Health and Ageing, Office for Aboriginal and Torres Strait Islander Health (OATSIH) - 27 July 2011 Read summary and report.
Joint study by Australian, Northern Territory, South Australian and West Australian Governments to develop feasible clinical service delivery models and care pathways to best meet (current and projected) needs for Indigenous Australian patients from remote communities requiring dialysis in Central Australia. It assessed current issues surrounding delivery of renal services in Central Australia.
OTHER STUDIES IN COLLABORATION WITH KIDNEY HEALTH AUSTRALIA
Two of a KinD (Kidneys in Diabetes) Report
Report commissioned by Kidney Health Australia to quantify the burden of diabetic kidney disease in Australia and the cost effectiveness of screening people with type 2 diabetes - released 17 June 2011
Two of a KinD (Kidneys in Diabetes) Access Report - Key Findings
This report concludes that an annual and simple kidney health test (a urine test followed by a blood test for those with excess protein in their urine) would prolong the lives of thousands of type 2 diabetes patients and significantly reduce the need for kidney dialysis and transplantation.
Contributors: Dr Tim Mathew, Medical Director - Kidney Health Australia, Dr Mukesh Haikerwal AO, Professor Stephen Colagiuri - University of Sydney. We thank Dr Jonathan Shaw from Baker IDI Heart and Diabetes Institute, for providing access to unpublished data from AusDiab, and Professor Alan Cass - The George Institute for Global Health, for providing data on previous modelling undertaken on cost effectiveness of screening for CKD. We also thank Brian Livingston and Associate Professor Stephen McDonald - ANZDATA, for their efficiency in assisting with additional data. Research undertaken and report prepared by Deloitte Access Economics for Kidney Health Australia, funded by an unconditional grant from Boehringer Ingelheim. In no way has Boehringer Ingelheim had any part in the direction, analysis or findings contained within this report.
Economic Impact of End-Stage Kidney Disease in Australia - Projections to 2020
Read Executive Summary or full report Release November 2010
The cost of treating end-stage kidney disease from 2009 to 2020 is estimated to be around $12 billion to the Australian Government. This reports reveals the incidence of kidney disease is growing at a serious rate, projected to increase by more than 54% to 2020. Report estimates that increasing the use of home dialysis over the next 10 years would lead to an estimated net savings of between $378 and $430 million for our health system. Annual costs per person for home dialysis is $49,137, compared to $79,072 for hospital dialysis.
Report commissioned to review and update the first comprehensive research into the Economic Burden of Kidney Disease in Australia (2006). The George Institute for Global Health assures the integrity of the data and appropriateness of the analyses.
Report funded by an unrestricted educational grant from Roche Australia. Research undertaken and report written by academics from The George Institute for Global Health Sydney Medical School and Centre for Obesity, Diabetes and Cardiovascular Disease at the University of Sydney, Royal Prince Alfred Hospital, Concord Repatriation General Hospital and Central Northern Adelaide Renal and Transplantation Service. Data presented is drawn from Australian and New Zealand Dialysis and Transplant Registry (ANZDATA). Analysis and conclusions presented are the responsibility of the authors, not ANZDATA Registry.
Contributors: Alan Cass, Steven Chadban, Martin Gallagher, Kirsten Howard, Alexandra Jones, Stephen McDonald, Paul Snelling and Sarah White. Corresponding author: Prof Alan Cass, Senior Director, George Institute for Global Health, PO Box M201 (Missenden Rd) Sydney 2050 Australia - call 02 9993 4553.
|
KIDNEY HEALTH AUSTRALIA - POSITION STATEMENTS AND PUBLICATIONS
All guidelines developed by Kidney Health Australia in collaboration with organizations are developed by expert health professionals and approved by our Medical and Scientific Advisory Committee and reviewed by our Board of Directors.
Kidney Health Australia Position Statement on drinking water April 2008 - Drink water instead!
|
 CHRONIC KIDNEY DISEASE MANAGEMENT IN GENERAL PRACTICE
The CKD Manager in General Practice book is formally endorsed by RACGP, ANZSN and Kidney Health Australia. It provides a comprehensive summary of current guidelines and clinical tips to help identify, manage and refer CKD in general practice in Australia. Find out more here - including how to order this popular resource.
-
How to treat Chronic Kidney Disease When and how to screen for and treat CKD
Australian Doctor: March 2010 - Contributors: A/Prof Tim Mathew (SA) - KHA Medical Director (SA) and Prof David Johnson (QLD) - Chair, Kidney Check Australia Taskforce
Renal Drug Reference Guide
$77A each www.renaldrugreference.com.au Contact Matthew Cervelli +61 408 846 901 info@renaldrugreference.com.au
Following introductory principles on the use of drugs in patients with renal impairment, this guide is structured into 13 colour coded therapeutic chapters including; anaemia, analgesia, antihistamines, anti-infectives, cardiovascular, endocrine & metabolic disorders, gastrointestinal, genitourinary, immunosuppressants, musculoskeletal, neurology and psychotropics. As well as being evidence based, this information is practical and written expressly for the prescriber who is searching for easy to comprehend, definitive advice.
Edited by Matthew Cervelli, forward Dr Tim Mathew (KHA Medical Director) Professor Graeme Russ (Queen Elizabeth Hospital) and published with assistance of Kidney Health Australia and unrestricted support of various pharmaceutical industry partners. Guide intended for healthcare professionals who are able to exercise independent professional clinical judgement when using the information contained within and is not intended for direct use by healthcare consumers.
|
SURVEYS ON DIALYSIS IN AUSTRALIA
Patient Perspectives on Dialysis First National Census (March 2011)
Results of first national census of patients on dialysis in Australia - read full report here.
How Australian nephrologists view home dialysis: Results of a national survey
Nephrology 2011;16:446-52. Ludlow MJ, George CRP, Hawley CM, Mathew TH, Agar JWM, Kerr PG, Lauder LA
Aim: Australia's commitment to home dialysis therapies has been significant. However, there is marked regional variation in the uptake of home haemodialysis (HD) and peritoneal dialysis (PD) suggesting further scope for the expansion of these modalities.
Methods: Between 1 April and 5 August 2009, Australian nephrologists were invited to complete an online survey. Seventy-six questions were asked covering characteristics of the dialysis units, responders' experience, adequacy of facilities and support structures, attitudes to the use of home HD and PD and issues impeding the increased uptake of home dialysis.
Conclusions: The most commonly reported impediments to expanding home dialysis services were financial disadvantage for home HD patients, and lack of physical infrastructure for training, support and education. Areas of concern for expanding home dialysis programs included psychiatry support, access to respite care and home visits, and lack of support from medical administration and government. The majority of nephrologists would recommend home dialysis to more patients if these impediments could be overcome
Australian Nephrology Nurses Views on Home Dialysis: A National Survey
Lauder, LA., Ludlow MJ, Hawley CM, Richardson EP, Mathew, TH & Munro, CE. (2011). Australian Nephrology Nurses views on home dialysis: A National Survey. Ren Soc Aust J 7(1) 6-12
Background: Home dialysis has the potential for significant clinical, psychosocial and economic advantages for the patient and the health system. There is regional variation in the uptake of home dialysis in Australia, suggesting further scope for the expansion of these modalities.
Methods: Between 1 and 5 August 2009 Australian senior nephrology nurses were invited to complete an online or hard copy survey. Thirty-four questions were asked regarding responders’ experience, adequacy of facilities and support structures, attitudes to the use of home dialysis and issues impeding the increased uptake of home dialysis.
Conclusion: Nephrology nurses also identified educational, cultural and organisational impediments that are preventing the growth of home dialysis. Other areas of concern for home dialysis programs included limited access to mental health services and respite care for people dialysing at home, and a lack of support from medical administration, area health services and government.
|
QUICK LINKS UPDATED 12 DECEMBER 2011
KHA webpages: Kidney Check Australia Taskforce (KCAT) I KHA - CARI Guidelines
Patient Education Resources: Fact Sheets I Publications I Transplantation I Resource Order Form
This site complies with HONcode standard for trustworthy health information: verify here |